Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence-Reference-Cited by-同舟云学术

Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence

Published:2022-11-02 Issue:11-12 Volume:16 Page:1213-1226
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Morjaria Jaymin B.¹,Campagna Davide²³⁴⁵,Caci Grazia⁶,O’Leary Renee³⁷,Polosa Riccardo²³⁵⁷⁸

Affiliation:

1. Department of Respiratory Medicine, Guy’s & St Thomas’ NHS Foundation Trust, Harefield Hospital, Harefield, UK

2. U.O.C. MCAU, University Teaching Hospital ‘Policlinico-Vittorio Emanuele’, University of Catania, Catania, Italy

3. Centre for the Prevention and Treatment of Tobacco Addiction (CPCT), Teaching Hospital “Policlinico - V. Emanuele”, University of Catania, Catania, Italy

4. Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy

5. Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy

6. Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), Università di Catania, Catania, Italy

7. ECLAT Srl, Spin-off of the University of Catania, Catania, Italy

8. Institute of Internal Medicine, AOU “Policlinico - V. Emanuele – S. Marco”, Catania, Italy

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2023.2167716

Reference137 articles.

1. World Health Organization (WHO). The top 10 causes of death. 2020. [cited 2022 Mar 03] Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

2. Pathogenesis of Chronic Obstructive Pulmonary Disease

3. Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD

4. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. cited Sept 2017. 2010. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.

5. Clearing the smoke: the science base for tobacco harm reduction---executive summary

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential health effects associated with electronic-cigarette;Environmental Research;2024-03

2. Economic Gains of Transitioning Towards Reduced-Risk Products: Evidence from Mexico;2024-01-11

3. Varenicline for smoking cessation in individuals who smoke cigarettes and use electronic cigarettes: a double-blind, randomised, placebo-controlled phase 3 trial;eClinicalMedicine;2023-12

4. A multicenter prospective randomized controlled trial investigating the effects of combustion-free nicotine alternatives on cardiovascular risk factors and metabolic parameters in individuals with type 2 diabetes who smoke: the DiaSmokeFree study protocol;Internal and Emergency Medicine;2023-11-24

5. Global health survey of people who vape and never smoked. Protocol for the Vaping Effects: Real-world InTernAtional Surveillance (VERITAS) Study (Preprint);2023-11-02